E. Vanni

1.1k total citations · 1 hit paper
23 papers, 867 citations indexed

About

E. Vanni is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E. Vanni has authored 23 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 5 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E. Vanni's work include Liver Disease Diagnosis and Treatment (14 papers), Diet, Metabolism, and Disease (4 papers) and Adipose Tissue and Metabolism (3 papers). E. Vanni is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Diet, Metabolism, and Disease (4 papers) and Adipose Tissue and Metabolism (3 papers). E. Vanni collaborates with scholars based in Italy, Australia and United Kingdom. E. Vanni's co-authors include Elisabetta Bugianesi, Mario Rizzetto, Gianfranco Pagano, Eleuterio Ferrannini, V. Ponti, Simona Baldi, Amalia Gastaldelli, Maurizio Cassader, Roberto Gambino and Giulio Marchesini and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Journal of Hepatology.

In The Last Decade

E. Vanni

21 papers receiving 855 citations

Hit Papers

Insulin resistance in non-diabetic patients with non-alco... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Vanni Italy 7 722 430 211 144 142 23 867
Rochelle Collantes United States 13 938 1.3× 332 0.8× 195 0.9× 122 0.8× 378 2.7× 19 1.1k
M Rosselli Argentina 10 790 1.1× 419 1.0× 148 0.7× 260 1.8× 161 1.1× 10 1.0k
Yasushi Ide Japan 8 447 0.6× 275 0.6× 223 1.1× 103 0.7× 168 1.2× 19 700
Halil Genç Türkiye 17 557 0.8× 253 0.6× 146 0.7× 120 0.8× 103 0.7× 35 889
Maria Antonella Burza Sweden 15 665 0.9× 401 0.9× 130 0.6× 106 0.7× 240 1.7× 21 985
Sreevidya Subbarayan United States 7 665 0.9× 431 1.0× 118 0.6× 119 0.8× 226 1.6× 10 798
Hiroyoshi Taketani Japan 17 496 0.7× 296 0.7× 89 0.4× 115 0.8× 198 1.4× 28 640
Dan Nakano Japan 18 910 1.3× 479 1.1× 208 1.0× 157 1.1× 387 2.7× 45 1.2k
Cemal Nuri Erçin Türkiye 18 512 0.7× 243 0.6× 79 0.4× 162 1.1× 136 1.0× 37 885
Ramy Younes Italy 15 1.1k 1.5× 534 1.2× 208 1.0× 212 1.5× 422 3.0× 37 1.3k

Countries citing papers authored by E. Vanni

Since Specialization
Citations

This map shows the geographic impact of E. Vanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Vanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Vanni more than expected).

Fields of papers citing papers by E. Vanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Vanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Vanni. The network helps show where E. Vanni may publish in the future.

Co-authorship network of co-authors of E. Vanni

This figure shows the co-authorship network connecting the top 25 collaborators of E. Vanni. A scholar is included among the top collaborators of E. Vanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Vanni. E. Vanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanni, E., Christophe Beauloye, Sandrine Horman, & Luc Bertrand. (2024). AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure. Essays in Biochemistry. 68(3). 363–377. 4 indexed citations
3.
Gaia, Silvia, E. Vanni, Daniela Campion, et al.. (2018). Is stiffness reliable for the detection of liver fibrosis in HCV patients treated with direct acting antiviral drugs (DAAs)? A prospective cohort study. Digestive and Liver Disease. 50(1). 36–36. 2 indexed citations
6.
Petta, Salvatore, E. Vanni, Elisabetta Bugianesi, et al.. (2015). PNPLA3 RS738409 I748M is associated with steatohepatitis in non obese subjects with hepatitis C. Digestive and Liver Disease. 47. e27–e27. 1 indexed citations
7.
Donati, Benedetta, E. Vanni, Paola Dongiovanni, et al.. (2015). O071 : Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash. Journal of Hepatology. 62. S226–S226. 1 indexed citations
8.
Mangia, Alessandra, Leonardo Mottola, D. Petruzzellis, et al.. (2011). 851 GENETIC PREDICTORS OF STEATOSIS AND FIBROSIS IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 54. S339–S340. 1 indexed citations
9.
Valenti, Luca, Simona Moscatiello, E. Vanni, et al.. (2010). Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study. QJM. 104(2). 141–149. 64 indexed citations
10.
Valenti, Luca, Ahmad Al‐Serri, Ann K. Daly, et al.. (2010). 127 HOMOZYGOSITY FOR THE PNPLA3/ADIPONUTRIN I148M POLYMORPHISM INFLUENCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Journal of Hepatology. 52. S57–S57. 28 indexed citations
11.
Gaia, Silvia, Emanuela Rolle, P. Carucci, et al.. (2009). 995 A COMPARATIVE STUDY BETWEEN ULTRASOUND EVALUATION, LIVER STIFFNESS MEASUREMENT AND BIOPSY FOR STAGING OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE. Journal of Hepatology. 50. S361–S361. 1 indexed citations
12.
Valenti, Luca, Anna Ludovica Fracanzani, Paola Dongiovanni, et al.. (2007). [769] IRON DEPLETION BY PHLEBOTOMY IMPROVES INSULIN RESISTANCE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERFERRITINEMIA; EVIDENCE FROM A CASE CONTROL STUDY. Journal of Hepatology. 46. S288–S289. 5 indexed citations
13.
Bugianesi, Elisabetta, Amalia Gastaldelli, E. Vanni, et al.. (2005). Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 48(4). 634–642. 590 indexed citations breakdown →
14.
Bugianesi, Elisabetta, Claudio Zannoni, E. Vanni, Rebecca Marzocchi, & Giulio Marchesini. (2004). Non-alcoholic fatty liver and insulin resistance: a cause–effect relationship?. Digestive and Liver Disease. 36(3). 165–173. 80 indexed citations
15.
Marchesini, Giulio, Rita Manini, E. Vanni, et al.. (2003). Ghrelin in non-alcoholic fatty liver disease. Journal of Hepatology. 38. 191–191. 1 indexed citations
16.
Marchesini, Giulio, Uberto Pagotto, Elisabetta Bugianesi, et al.. (2003). Low Ghrelin Concentrations in Nonalcoholic Fatty Liver Disease Are Related to Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 88(12). 5674–5679. 52 indexed citations
17.
Leone, Nicola, E. Vanni, F. Brunello, et al.. (2002). 22 OC Expanding the natural history of non-alcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular. Digestive and Liver Disease. 34. A54–A54. 2 indexed citations
18.
Pellicano, Rinaldo, E. Vanni, Marco Astegiano, et al.. (2001). Diagnosis of Helicobacter pylori infection: validation of a commercial non invasive salivary test against urea breath test and serology.. PubMed. 47(3). 111–6. 3 indexed citations
19.
Pellicano, Rinaldo, Nicola Leone, E. Vanni, et al.. (2000). Previous tuberculosis, hepatitis C virus and lichen planus. A report of 10 cases, a causal or casual link?. PubMed. 42(1). 77–81. 8 indexed citations
20.
Vanni, E., Rinaldo Pellicano, B. Demarchi, et al.. (1999). Management of duodenal ulcer disease in the era of H. pylori.. PubMed. 45(2). 89–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026